Condition
Nose Deformities, Acquired
Total Trials
7
Recruiting
0
Active
0
Completed
4
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
28.6%
2 terminated out of 7 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
29%
2 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Completed4
Terminated2
Withdrawn1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT03624608Not ApplicableTerminated
Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
NCT04334590Withdrawn
Fabrication of Sequential Naso-Alveolar Molding Appliances in the Treatment of Cleft Lip/Nose Deformities
NCT02815345Not ApplicableTerminatedPrimary
Objectives and Measures Dimensions Nasal Resistance of Preterm and Term (MODERN)
NCT02603796CompletedPrimary
3D Imaging of Neonatal Faces
NCT01827020Phase 4CompletedPrimary
Effect of Ketamine Addition to Lidocaine in Rhinoplasty
NCT00545428Not ApplicableCompletedPrimary
Mastoid Bone Autograft for Dorsal Nasal Augmentation
NCT00467714Phase 4CompletedPrimary
Evaluation Of Cloumella Strut Effect In Tip Rotation
Showing all 7 trials